<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ALS Archives - Fit Found Me</title>
	<atom:link href="https://fitfoundme.com/tag/als/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Healthy Living</description>
	<lastBuildDate>Mon, 29 Dec 2025 06:18:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://fitfoundme.com/wp-content/uploads/2017/11/cropped-new-fit-found-me-favicon-32x32.png</url>
	<title>ALS Archives - Fit Found Me</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>ALS Research Reaches Turning Point With Gene Targeted Treatment</title>
		<link>https://fitfoundme.com/new-als-drug-slows-progression-small-patient-group/</link>
					<comments>https://fitfoundme.com/new-als-drug-slows-progression-small-patient-group/#comments</comments>
		
		<dc:creator><![CDATA[Michelle]]></dc:creator>
		<pubDate>Mon, 26 Dec 2022 16:36:17 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Wellness]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[genetic medicine]]></category>
		<category><![CDATA[medical breakthroughs]]></category>
		<category><![CDATA[motor neuron disease]]></category>
		<category><![CDATA[neurology research]]></category>
		<category><![CDATA[Qalsody]]></category>
		<category><![CDATA[rare diseases]]></category>
		<category><![CDATA[SOD1 mutation]]></category>
		<category><![CDATA[tofersen]]></category>
		<guid isPermaLink="false">https://fitfoundme.com/?p=35044</guid>

					<description><![CDATA[<p>For decades, a diagnosis of amyotrophic lateral sclerosis has carried with it an almost unbearable certainty. Patients and families are told to prepare for relentless decline, loss of independence, and a future measured not in years, but often in months. Treatments approved over the years have offered only modest extensions of life, with effects so &#8230;</p>
<p>The post <a href="https://fitfoundme.com/new-als-drug-slows-progression-small-patient-group/">ALS Research Reaches Turning Point With Gene Targeted Treatment</a> appeared first on <a href="https://fitfoundme.com">Fit Found Me</a>.</p>
]]></description>
		
					<wfw:commentRss>https://fitfoundme.com/new-als-drug-slows-progression-small-patient-group/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
	</channel>
</rss>
